SELECTED PEER-REVIEWED PUBLICATIONS

  • Bell, SC., Mall, MA., Gutierrez, H., Ratjen, F. et al. (2020). The future of cystic fibrosis care: a global perspective. Lancet Respir Med Volume 8, Issue 1, January 2020, Pages 65-124. [abstract]
  • Shaw, M., Oppelaar, M. C., Jensen, R., Stanojevic, S., Davis, S. D., Retsch‐Bogart, G., & Ratjen, F. A. (2020). The utility of moment ratios and abbreviated endpoints of the multiple breath washout test in preschool children with cystic fibrosis. Pediatric Pulmonology55(3), 649–653. doi: 10.1002/ppul.24618 [abstract]
  • Anagnostopoulou, Pinelopi, et al. “Normative Data for Multiple Breath Washout Outcomes in School-Aged Caucasian Children.” European Respiratory Journal, 2019, p. 1901302., doi:10.1183/13993003.01302-2019. [abstract]
  • Grasemann, H., Klingel, M., Avolio, J., Prentice, C., Gonska, T., Tullis, E., & Ratjen, F. (2019). Long-term effect of CFTR modulator therapy on airway nitric oxide. European Respiratory Journal55(1), 1901113. doi: 10.1183/13993003.01113-2019 [abstract]
  • Saunders, C., Jensen, R., Robinson, P. D., Stanojevic, S., Klingel, M., Short, C., … Ratjen, F. (2019). Integrating the multiple breath washout test into international multicentre trials. Journal of Cystic Fibrosis. doi: 10.1016/j.jcf.2019.11.006 [abstract]
  • Ratjen, F., Jensen, R., Klingel, M., Mcdonald, R., Moore, C., Benseler, N., . . . Stanojevic, S. (2019). Effect of changes in tidal volume on multiple breath washout outcomes. Plos One, 14(7). doi:10.1371/journal.pone.0219309 [abstract]
  • Klingel, M., Stanojevic, S., Tullis, E., Ratjen, F., & Waters, V. (2019). Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis. Annals of the American Thoracic Society, 16(7), 861-867. doi:10.1513/annalsats.201811-774oc [abstract]
  • Ratjen, F., Davis, SD., Stanojevic S., Kronmal RA., Hinckley Stukovsky KD. (2019). Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Respir Med, S2213-2600(19)30187-0. doi: 10.1016/S2213-2600(19)30187-0. [abstract]
  • Perrem, L., Stanojevic, S., Solomon, M., Carpenter, S., & Ratjen, F. (2019). Incidence and risk factors of paediatric cystic fibrosis-related diabetes. Journal of Cystic Fibrosis. doi:10.1016/j.jcf.2019.04.015 [abstract]
  • Rayment, J. H., Couch, M. J., Mcdonald, N., Kanhere, N., Manson, D., Santyr, G., & Ratjen, F. (2019). Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis. European Respiratory Journal, 53(5), 1802188. doi:10.1183/13993003.02188-2018 [abstract]
  • Perrem, L., Rayment, J. H., & Ratjen, F. (2018). The lung clearance index as a monitoring tool in cystic fibrosis. Current Opinion in Pulmonary Medicine, 1. doi:10.1097/mcp.0000000000000515 [abstract]
  • Ratjen, F., Klingel, M., Black, P., Powers, M. R., Grasemann, H., Solomon, M., . . . Rosenfeld, M. (2018). Changes in Lung Clearance Index in Preschool Cystic Fibrosis Patients Treated with Ivacaftor. American Journal of Respiratory and Critical Care Medicine. doi:10.1164/rccm.201802-0243le [abstract]
  • Robinson, PD., et al. “Comparison of Facemask and Mouthpiece Interfaces for Multiple Breath Washout Measurements.” Journal of Cystic Fibrosis, 2018, doi:10.1016/j.jcf.2018.01.003. [abstract]
  • Robinson, PD., et al. “Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement.” American Journal of Respiratory and Critical Care Medicine, vol. 197, no. 5, 2018, doi:10.1164/rccm.201801-0074st. [abstract]
  • Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis. Thorax Published Online First: 15 February 2018. doi: 10.1136/thoraxjnl-2017-210979. [abstract]
  • Stanojevic, S., Davis, SD., Retsch-Bogart, G., Webster, H., Davis, M., Johnson, RC., Jensen, R., Pizarro, ME., Kane, M., Clem, CC., Schornick, L., Subbarao, P., Ratjen, F. (2017). Progression of lung disease in preschool patients with cystic fibrosis. Am J Respir Crit Care Med, 195(9), 1216–1225. [abstract]
  • Kane M, Rayment JH, Jensen R, McDonald R, Stanojevic S, Ratjen F (2017) Correcting for tissue nitrogen excretion in multiple breath washout measurements. PLoS ONE 12(10): e0185553. [abstract]
  • Engberink, E.O., Ratjen, F., Davis, SD., Retsch-Bogart, G., Amin, R., Stanojevic, S. (2017).  Inter-test reproducibility of the lung clearance index measured by multiple breath washout. European Respiratory Journal, Oct 5;50(4) 1700433. [abstract]
  • Rayment, J., Ratjen, F. Constrictive bronchiolitis: A distinct phenotype of CF lung disease? Am J Resp Crit Care Med. Accepted September 21.
  • Ratjen F. How best to capture early CF lung disease? Am J Resp Crit Care Med. Accepted September 17.
  • Stanojevic, S., Mcdonald, A., Waters, V., Macdonald, S., Horton, E., Tullis, E., & Ratjen, F. (2016). Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.Thorax. [abstract]
  • Stanojevic, S., & Ratjen, F. (2016). Physiologic endpoints for clinical studies for cystic fibrosis. Journal of Cystic Fibrosis, 15(4), 416-423.[abstract]
  • Engberink, E.O., Stanojevic, S., & Ratjen, F. (2016). Clinimetric Properties of the Lung Clearance Index in Adults and Children With Cystic Fibrosis. Chest, 150(6), 1412-1413. doi:10.1016/j.chest.2016.08.1478 [abstract]
  • Wettlaufer, J., Klingel, M., Yau, Y., Stanojevic, S., Tullis, E., Ratjen, F., Waters V. (2016) Longitudinal Study of Stenotrophomonas Maltophilia antibody levels and outcomes in cystic fibrosis patients. Journal of Cystic Fibrosis [abstract]
  • Jensen, R., Stanojevic, S., Klingel, M., Pizarro, M. E., Hall, G. L., Ramsey, K., . . . Ratjen, F. (2016). A Systematic Approach to Multiple Breath Nitrogen Washout Test Quality. PLOS ONE PLoS ONE, 11(6).[abstract]
  • Amin, R., Stanojevic, S., Kane, M., Webster, H., Ratjen, F. (2016) A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis. Respiratory Medicine; (112):59-64. [abstract]
  • Ratjen, F. (2016). Pulmonary artery hypertension: An underrated disease manifestation in cystic fibrosis? The Lancet Respiratory Medicine, 4(8), 596-598. [abstract]
  • Ratjen, F., Waters, V., Klingel, M., Mcdonald, N., Dell, S., Leahy, T. R., . . . Grasemann, H. (2015). Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J European Respiratory Journal, 47(3), 829-836. [abstract]
  • Kane, M., Gonska, T., Jensen, R., Avolio, J., Klingel, M., Stanojevic, S., Ratjen, F. (2016) Lung clearance index response in CF patients with class III CFTR mutations. Thorax; 71(5):476-7. [abstract]
  • Waters, V., Stanojevic, S., Klingel, M., Chiang, J., Sonneveld, N., & Kukkar, R. et al. (2015). Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations. Journal Of Cystic Fibrosis, 14(6), 770-776. [abstract]
  • Sonneveld, N., *Stanojevic, S., Amin, R., Aurora, P., Davies, J., Elborn, JS., Horsely, A., Latzin, P., O’Neill, K., Robinson, P., Scrase, E., Selvadurai, H., Subbarao, P., Welsh, L., Yammine, S., Ratjen, F. (2015) Lung Clearance Index in cystic fibrosis subjects treated for pulmonary exacerbations. European Respiratory Journal; 46(4):1055-64. [abstract]

SELECTED CONFERENCE ABSTRACTS

  • Kane, M., Stanojevic, S., Jensen, R., Ratjen, F. 2016 Effect of Tissue Nitrogen Excretion on Multiple Breath Washout Measurements. European Respiratory Society, London, UK.
  • Stanojevic, S., Graham, B., Cooper, B., Thompson, B., Carter, K., Hall, G. 2016 Global lung function initiative: Reference equations for the transfer factor for carbon monoxide (TLCO). European Respiratory Society, London, UK.
  • Ratien F, Alon N,Maykut R, Liu C, Angyalosi TOBI® for eradication of early P. aeruginosa infection in paediatric cystic fibrosis patients: the EARLY study. J Cyst Fibros. 15; Suppl 1. S1.
  • Stanojevic, S., Jensen, R., Webster, H., Kane M., Pizarro, M., Davis, S., Retsch-Bogart, G., Subbarao, P., Ratjen, F. 2016 Tracking pulmonary exacerbations in preschool children using the lung clearance index. European Respiratory Society, London, UK.
  • Klingel, M., Isaac, S., Raaijmakers, L., Jensen, R., Stanojevic, S., Ratjen, F. 2016 O2 concentration based definition of wait times between multiple breath nitrogen washout trials. European Respiratory Society, London, UK.
  • Jensen, R., Pizarro, M. Klingel, M., Stanojevic, S., Webster, H., McDonald, N., Subbarao, P., Davis, S.D., Retsch-Bogart, G.Z., Pittman, J.E., Ratjen, F. 2015 Progression and variability of LCI in preschool children with Cystic Fibrosis. North American Cystic Fibrosis Conference, Phoenix, USA.